Physician profile
Antonio Eugenio Cornier
NPI 1326321498
$638.83
in general payments reported to CMS, 2019-2025
9 companies · $86.99 in 2025
The $86.99 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.08 · 2020: $19.23 · 2021: $106 · 2022: $43.96 · 2023: $209 · 2024: $133 · 2025: $86.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365 · Consulting Fee: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.50 |
| Consulting Fee | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $228.59 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Alk-Abello, INC | $88.64 | 2023-2025 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $84.06 | 2019-2024 | |
| Cranial Technologies, INC | $76.08 | 2022-2024 | Doc Band |
| Baxter Healthcare | $65.00 | 2023 | |
| Sanofi Pasteur INC. | $34.13 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $29.00 | 2021 | |
| Glaxosmithkline, LLC. | $17.23 | 2021 | |
| Seqirus USA INC | $16.10 | 2024 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Cornier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.